Senores Pharmaceuticals and Dr. Reddy’s Laboratories announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of Merck Sharp and Dohme LLC in the U.S. market. The product will be marketed by Dr. Reddy’s. “We are pleased to …
Shilpa Medicare’s Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana Healthcare Limited, Shilpa Medicare group company) along with its partner Shorla Oncology announces that the USFDA has approved IMKELDI (imatinib oral solution), the first oral liquid form of imatinib …
IMMACULE – (MANUFACTURER OF LIQUID AND LYOPHILIZED INJECTIONS). Approvals – UK-MHRA, ANVISA, PICS, INVIMA, US FDA* Immacule provides world-class expertise in Lyophilized products with consistency in quality, delivery and competive pricing. Our state-of-the-art manufacturing facility is designed to comply with regulated markets pricing and Our global …
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution). Glenmark’s Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004% of Sandoz. According to IQVIATM sales data …
Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities …
Aspiro Pharma is one of the fast growing pharmaceutical companies in India fully dedicated to research, development and manufacturing of Generic Parenteral Formulations. Established in 2012, Aspiro specializes in manufacturing Powder, Lyophilized and Liquid products in the form of injectables, ophthalmics, Pre-filled Syringes (PFS) and IV …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
